ESCO Corporation Announces CEO Transition Plan
President and COO
Current CEO
Current CEO,
“Cal Collins is the ideal candidate to take on the CEO role. He has a strong institutional knowledge of ESCO and has honed his operational skills and strategic acumen over the past decade with the company,” said
Collins joined ESCO in 2000 as Assistant
Pratt added, “I have thoroughly enjoyed the 40 years in which I have had the privilege to work with the talented individuals that make up the ESCO family. It’s been my honor to help build this organization into a global leader in the industry and I look forward to continuing to support the company in 2012 and beyond as Chairman of the Board.”
“Everyone at ESCO truly appreciates the exceptional leadership Steve has provided over the years and I have great respect for the legacy I inherit,” said
Pratt has been employed with ESCO for his entire career, beginning in 1972. His nearly 40 years of service includes plant management roles, President of the
About
Headquartered in
Kelley Egre, 503-778-6456
[email protected]
Source:


A.M. Best Upgrades Ratings of State Farm General Insurance Company
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
- Life insurance and annuities: Reassuring ‘tired’ clients in 2026
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
- Report Summarizes Kinase Inhibitors Study Findings from Saga University Hospital (Simulation of Perioperative Ibrutinib Withdrawal Using a Population Pharmacokinetic Model and Sparse Clinical Concentration Data): Drugs and Therapies – Kinase Inhibitors
- Flawed Social Security death data puts life insurance benefits at risk
- EIOPA FLAGS FINANCIAL STABILITY RISKS RELATED TO PRIVATE CREDIT, A WEAKENING DOLLAR AND GLOBAL INTERCONNECTEDNESS
- Envela partnership expands agent toolkit with health screenings
More Life Insurance News